No abstract

No abstract

TRAPS is a cause of recurrent pericarditis in 6% of unselected cases with recurrent pericarditis. A positive family history for pericarditis or periodic fever syndromes, a poor response to colchicine, recurrences after the first year from the index attack or on colchicine treatment, as well as the need of immunosuppressive agents are clues of the possible presence of TNFRSF1A gene mutations in patients with recurrent pericarditis.

The cytotoxicity of Au/Ag nanoparticles (NPs) on human spermatozoa was investigated in vitro. Semen from donors were incubated (37 °C, 60'-120') with 30, 60, 125, 250 and 500 μM Au/Ag-NPs. Sperm motility was evaluated following WHO guidelines; sperm viability was assessed with eosin Y test. Au-NPs were characterised and localised with field emission gun-based scanning transmission electron microscope/energy dispersive spectroscopy and transmission electron microscopy. Both tested NPs exerted a significant dose-dependent effect on motility and viability of human spermatozoa (P < 0.001). Ag-NPs seem to show a slightly elevated toxicity although not significant (P > 0.05). Au-NPs were localised in spermatozoa, whereas Ag-NPs were undetectable. In conclusion, Au-NPs and Ag-NPs do not appear to be harmful for human spermatozoa up to high concentrations (250-500 μM) that are probably difficult to reach in vivo. It is mandatory to explore the genotoxic effect of NPs in germ cells.

SAP with the aid of a re-entry device for TASC C and D lesions of the SFA seems to be safe and clinically effective in patients suffering from CLI, according to the experience at our centre. Further follow-up and more data are necessary to confirm these findings.

No abstract

The results from our study confirm that the beneficial effects of spa therapy in patients with knee osteoarthritis lasts over time, with positive effects on the painful symptomatology and a significant improvement on functional capacities. Spa therapy can represent a useful backup to pharmacologic treatment of knee osteoarthritis or a valid alternative for patients who do not tolerate pharmacologic treatments.

Guaranteeing high acaricide efficacy to control Varroa destructor is fundamental for colony survival. In this study, we verified the efficacy and impact of a commercial thymol-based veterinary product (Apiguard®) on colony honey bee populations when used alone or combined with the biotechnical method of caging honey bee queens to create an artificial brood interruption period in the colony. Apiguard® killed 76.1% of the mites while queen caging killed 40.6% of the mites. The combination of Apiguard® administration with queen caging killed 96.8% of the mites. Comparing bee numbers before and after treatment, Apiguard® treated colonies with caged queens had 48.7% fewer bees compared to before treatment, while Apiguard® alone reduced the number of adult bees by 13.6%. None of the treatments in the different groups resulted in elevated queen mortality.Varroa destructor / thymol / Apiguard / queen caging / efficacy